Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 4|pp. 1959–1982
Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis
Back to articleFigure 4(4 of 8)
100%
Figure 4
Figure 4.The forest plot of HR for PFS in the subgroup analysis based on the DDR of paclitaxel. HR: hazard ratio; PFS: progression-free survival; DDR: dose density ratio.